Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression
Hepatocellular carcinoma (HCC) has the third-highest incidence in cancers and has become one of the leading threats to cancer death. With the research on the etiological reasons for cirrhosis and HCC, early diagnosis has been placed great hope to form a favorable prognosis. Non-invasive medical imag...
Main Authors: | Ying Zhang, Kazushi Numata, Yuewu Du, Shin Maeda |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.921667/full |
Similar Items
-
Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma
by: Akihiro Funaoka, et al.
Published: (2021-03-01) -
Prediction of Histological Grades and Ki-67 Expression of Hepatocellular Carcinoma Based on Sonazoid Contrast Enhanced Ultrasound Radiomics Signatures
by: Yi Dong, et al.
Published: (2022-09-01) -
Addition of contrast in ultrasound screening for hepatocellular carcinoma
by: Kathryn McGillen, et al.
Published: (2024-03-01) -
Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced Ultrasound
by: Sheng Chen, et al.
Published: (2022-09-01) -
Current Imaging Diagnosis of Hepatocellular Carcinoma
by: Evangelos Chartampilas, et al.
Published: (2022-08-01)